The brain imaging and neuroimaging market is witnessing substantial expansion in 2026 due to the increasing prevalence of neurological disorders such as Alzheimer’s disease, epilepsy, dementia, Parkinson’s disease, traumatic brain injuries, and stroke. Brain imaging and neuroimaging technologies play a vital role in identifying structural and functional abnormalities in the brain through advanced diagnostic systems including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), and functional MRI (fMRI).
The growing burden of neurological diseases across aging populations has significantly increased demand for accurate and early diagnostic imaging solutions. The brain imaging and neuroimaging market is also benefiting from advancements in artificial intelligence integration, cloud-based image analysis, portable imaging systems, and high-resolution scanners. Increasing healthcare investments, rising awareness regarding early neurological diagnosis, and technological innovations in imaging systems are further accelerating the growth of the brain imaging and neuroimaging market globally. Hospitals and diagnostic centers are increasingly adopting sophisticated imaging technologies to improve patient outcomes and support precision medicine approaches in neurology.
Continue reading for more details:
https://www.fortunebusinessinsights.com/brain-imaging-and-neuroimaging-market-111637
The brain imaging and neuroimaging market is segmented based on device type, product type, application, end user, and region. By device type, the market includes MRI systems, PET scanners, EEG systems, CT scanners, and other neuroimaging devices. MRI systems account for a significant share of the brain imaging and neuroimaging market due to their high accuracy in detecting brain abnormalities and soft tissue visualization. PET imaging is increasingly used for functional brain analysis and oncology-related neurological studies. EEG systems continue to gain traction for epilepsy diagnosis and brain activity monitoring. CT imaging remains widely utilized for emergency neurological assessments because of its rapid imaging capabilities.
Based on product type, the brain imaging and neuroimaging market is categorized into fixed and portable systems. Fixed systems dominate the market owing to their extensive installation in hospitals and large diagnostic centers. However, portable neuroimaging devices are witnessing strong growth due to increasing demand for point-of-care diagnostics and mobile healthcare services.
By application, the brain imaging and neuroimaging market covers brain tumors, dementia, multiple sclerosis, epilepsy, stroke, traumatic brain injuries, and other neurological conditions. Dementia and neurodegenerative disorders represent major application segments because of the growing geriatric population worldwide. Brain tumor diagnosis also contributes significantly to the brain imaging and neuroimaging market as advanced imaging technologies improve surgical planning and treatment monitoring.
On the basis of end user, the market is segmented into hospitals, specialty clinics, diagnostic imaging centers, ambulatory surgical centers, and research institutions. Hospitals hold the largest share in the brain imaging and neuroimaging market due to higher patient inflow, strong infrastructure, and increased adoption of advanced diagnostic equipment. Diagnostic imaging centers are also expanding rapidly due to increasing outpatient imaging procedures and growing accessibility to imaging technologies.